SUPN
Supernus Pharmaceuticals Inc
NASDAQ: SUPN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$48.55
-0.29% today
Updated 2026-04-29
Market cap
$2.80B
P/E ratio
—
P/S ratio
3.89x
EPS (TTM)
$-0.68
Dividend yield
—
52W range
$29 – $60
Volume
0.7M
Supernus Pharmaceuticals Inc (SUPN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |